4 terminated, 1 completed, 1 recruiting, 1 withdrawn. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Terminated 4, Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow Anaplastic Ependymoma: new trials by email Literature Review of Anaplastic Ependymoma trials Research Report on Anaplastic Ependymoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors LUTATHERAĀ® (Lutetium Lu 177 dotatate) - High Grade Glioma, Meningioma | Phase 1 / Phase 2 | Recruiting | Nationwide Children's Hospital | 65 | 2022-11-21 | 2026-11-16 |
| Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma Marizomib - Anaplastic Ependymoma, Ependymoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 4 | 2020-01-22 | 2022-07-27 |
| Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors imetelstat sodium - Anaplastic Astrocytoma, Anaplastic Ependymoma | Phase 2 | Terminated | Pediatric Brain Tumor Consortium | 43 | 2013-03-01 | 2018-07-20 |
| Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas AXL1717 - Glioblastoma, Gliosarcoma | Phase 1 / Phase 2 | Terminated | Rush University Medical Center | 10 | 2012-12-01 | 2023-05-22 |
| Carboplatin and Bevacizumab for Recurrent Ependymoma Carboplatin, Bevacizumab - Ependymoma, Anaplastic Ependymoma | Phase 2 | Completed | National Cancer Institute (NCI) | 35 | 2011-04-27 | 2025-08-05 |
| Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma ritonavir, lopinavir - Brain Tumor, Anaplastic Astrocytoma | Phase 2 | Terminated | Case Comprehensive Cancer Center | 19 | 2009-01-01 | 2013-06-10 |
| Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors Photodynamic therapy using Photosan and LumaCare⢠Lamp Model LC-122M - Malignant Intracranial Tumors, Glioblastoma Multiforme | Phase 2 | Withdrawn | National Taiwan University Hospital | 5 | 2010-01-12 |
Ependymoma (7) · Astrocytoma (4) · Glioblastoma (4) · Oligodendroglioma (4) · Glioma (3) · Gliosarcoma (3) · Brain Neoplasms (2) · Brain Stem Neoplasms (1) · Central Nervous System Neoplasms (1) · Diffuse Intrinsic Pontine Glioma (1) · Disease Progression (1) · Medulloblastoma (1) · Meningioma (1) · Neoplasms (1) · Neoplasms, Germ Cell and Embryonal (1)
Neoplasms by Histologic Type (7) · Neoplasms, Glandular and Epithelial (7) · Neoplasms, Nerve Tissue (7) · Neoplasms, Neuroepithelial (7) · Neuroectodermal Tumors (7) · Neoplasms (6) · Neoplasms, Germ Cell and Embryonal (6) · Brain Diseases (4) · Central Nervous System Diseases (4) · Glioma (4) · Neoplasms by Site (4) · Nervous System Diseases (4) · Nervous System Neoplasms (4) · Central Nervous System Neoplasms (3) · Brain Neoplasms (2)
Bevacizumab (1) · Carboplatin (1) · GRN163L peptide (1) · Lopinavir (1) · Ritonavir (1) · imetelstat (1) · lutetium Lu 177 dotatate (1) · marizomib (1) · picropodophyllin (1)
National Cancer Institute (NCI) (2) · Case Comprehensive Cancer Center (1) · National Taiwan University Hospital (1) · Nationwide Children's Hospital (1) · Pediatric Brain Tumor Consortium (1) · Rush University Medical Center (1)
United States (6) · Taiwan (1)
David Peereboom, MD (1) · Jui-Chang Tsai, M.D. Ph.D. (1) · Kevin Camphausen, M.D. (1) · Margot Lazow, MD (1) · Mark R Gilbert, M.D. (1) · Maryam Fouladi (1) · Robert Aiken, MD (1)
U01CA081457 (1)